文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

脂蛋白(a)、绝经激素治疗与绝经后个体冠心病风险。

Lipoprotein(a), Menopausal Hormone Therapy, and Risk of Coronary Heart Disease in Postmenopausal Individuals.

机构信息

Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.

Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston.

出版信息

JAMA Cardiol. 2022 May 1;7(5):565-568. doi: 10.1001/jamacardio.2022.0716.

DOI:10.1001/jamacardio.2022.0716
PMID:35377945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8981063/
Abstract

This observational study examines whether hormone therapy use modifies the association of lipoprotein(a) with coronary heart disease.

摘要

本观察性研究旨在探讨激素疗法的使用是否会改变脂蛋白(a)与冠心病之间的关联。

相似文献

[1]
Lipoprotein(a), Menopausal Hormone Therapy, and Risk of Coronary Heart Disease in Postmenopausal Individuals.

JAMA Cardiol. 2022-5-1

[2]
Postmenopausal hormone-replacement therapy, plasma lipoprotein[a], and risk for coronary heart disease.

J Lab Clin Med. 1994-6

[3]
Increased plasma concentrations of TGF-beta1 after hormone replacement therapy.

J Intern Med. 2000-2

[4]
Serum lipoprotein(a) dynamics before/after menopause and long-term effects of hormone replacement therapy on lipoprotein(a) levels in middle-aged and older Japanese women.

Horm Metab Res. 2006-9

[5]
Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy.

Haematologica. 2001-1

[6]
Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women.

J Am Coll Cardiol. 2000-2

[7]
Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.

JAMA. 2000-4-12

[8]
The effect of hormone replacement therapy on metabolism of lipoprotein remnants in postmenopausal women.

Maturitas. 2000-1-15

[9]
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

JAMA. 1998-8-19

[10]
Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.

Atherosclerosis. 1996-9-27

引用本文的文献

[1]
Association of Lipoprotein(a) With Cardiovascular and Cerebrovascular Disease in a Nationally Representative Cohort of Germany.

JACC Adv. 2025-7-23

[2]
Sex Differences in the Association Between Lipoprotein(a) and Cardiovascular Outcomes: The MGB Lp(a) Registry.

J Am Heart Assoc. 2025-5-6

[3]
Lipoprotein(a) throughout life in women.

Am J Prev Cardiol. 2024-10-29

[4]
Lipoprotein(a): Emerging insights and therapeutics.

Am J Prev Cardiol. 2024-3-29

[5]
High lipoprotein(a): Actionable strategies for risk assessment and mitigation.

Am J Prev Cardiol. 2024-4-3

[6]
Lipoprotein alterations in endocrine disorders - a review of the recent developments in the field.

Front Endocrinol (Lausanne). 2024

[7]
Lipoprotein(a) in patients with breast cancer after chemotherapy: exploring potential strategies for cardioprotection.

Lipids Health Dis. 2023-9-22

[8]
Yin Huo Tang, a traditional Chinese herbal formula, relives ovariectomy and empty bottle stimulation-induced menopause-like symptoms in mice.

Front Endocrinol (Lausanne). 2022

[9]
Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies.

J Clin Med. 2022-10-13

[10]
Menopausal hormone therapy does not lower Lp(a)-associated CHD risk.

Nat Rev Cardiol. 2022-6

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索